España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ImmuCell
ICCC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
ImmuCell (ICCC) Forecast
News
Earnings
ImmuCell (ICCC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ImmuCell (NASDAQ:ICCC) Stock
ImmuCell Stock (NASDAQ: ICCC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 16, 2025
ImmuCell Settles Insurance Claim For $426K Co...
Benzinga Newsdesk
Friday, January 10, 2025
Reported Earlier, ImmuCell Preliminary Q4 Sal...
Benzinga Newsdesk
Wednesday, November 13, 2024
ImmuCell Q3 GAAP EPS $(0.09) Up From $(0.12) ...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, October 08, 2024
ImmuCell Announces Preliminary Q3 Revenue Of ...
Benzinga Newsdesk
Tuesday, August 13, 2024
ImmuCell Sees Q2 $(0.20) Down From $(0.18) Yo...
Benzinga Newsdesk
Wednesday, July 10, 2024
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, July 09, 2024
ImmuCell shares are trading higher after the ...
Benzinga Newsdesk
ImmuCell Sees Prelim. Q2 Sales $5.47M Up From...
Benzinga Newsdesk
Wednesday, June 05, 2024
ImmuCell Updates Regulatory Status Of Product...
Benzinga Newsdesk
Tuesday, May 14, 2024
ImmuCell Reports $7.3M In Product Sales For Q...
Benzinga Newsdesk
Wednesday, May 08, 2024
ImmuCell Anticipates No Change To Preliminary...
Benzinga Newsdesk
Tuesday, April 09, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
ImmuCell Reports Preliminary, Unaudited Sales...
Benzinga Newsdesk
Tuesday, February 27, 2024
ImmuCell Q4 2023 EPS $(0.15) Up From $(0.22) ...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, January 08, 2024
ImmuCell Sees Prelim. Q4 Sales $5.1M, 2023 Sa...
Benzinga Newsdesk
Monday, November 13, 2023
ImmuCell Q3 2023 Gaap EPS $(0.12) Down From $...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Thursday, October 05, 2023
ImmuCell Announces Preliminary, Unaudited Sales Results For Q3 2023; Sees Q3 Revenue $5.4M Vs 4.8M YoY
Happy Mohamed
Tuesday, August 29, 2023
ImmuCell Announced That It Recently Submitted...
Benzinga Newsdesk
Thursday, August 10, 2023
ImmuCell Q2 EPS $(0.18) Down From $(0.09) YoY...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Wednesday, July 12, 2023
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
Lisa Levin
Tuesday, July 11, 2023
ImmuCell Preliminary Q2 Sales $3.53M Down Fro...
Benzinga Newsdesk
Wednesday, June 28, 2023
ImmuCell Announces Change In Timing Of Anticipated FDA Submission; Says 'Planned To Make Our Next FDA Submission During Q2 Of This Year, We Have Decided To Add One Additional Month To The Projected Regulatory Development Process For Re-Tain'
Happy Mohamed
Friday, May 12, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, May 11, 2023
ImmuCell Q1 EPS $(0.30) Down From $0.07 YoY, ...
Benzinga Newsdesk
Earnings Scheduled For May 11, 2023
Benzinga Insights
Wednesday, April 05, 2023
ImmuCell Sees Q1 Sales $3.45M Vs $6M YoY
Michael Horton
Thursday, March 16, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, February 21, 2023
ImmuCell Q4 EPS $(0.21) Down From $0.01 YoY, ...
Benzinga Newsdesk
Earnings Scheduled For February 21, 2023
Benzinga Insights
Monday, January 09, 2023
ImmuCell Prelim. Sales For Quarter Ended Dec....
Bill Haddad
Wednesday, December 14, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, November 21, 2022
ImmuCell Q3 EPS $(0.08) Down From $0.02 YoY, Sales $4.80M Miss $5.40M Estimate
Michael Horton
Earnings Scheduled For November 21, 2022
Benzinga Insights
Wednesday, October 05, 2022
ImmuCell Reports Prelim. Q3 Sales Of $4.8M, D...
Benzinga Newsdesk
Tuesday, September 06, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, August 11, 2022
ImmuCell Q2 EPS $(0.09) Down From $0.02 YoY, ...
Benzinga Newsdesk
Earnings Scheduled For August 11, 2022
Benzinga Insights
Thursday, July 07, 2022
ImmuCell Reports Q2 Prelim. Sales $3.9M Vs. $...
Benzinga Newsdesk
Thursday, May 12, 2022
ImmuCell Q1 EPS $0.09 Up From $(0.06) YoY, Sales $6.00M Beat $5.40M Estimate
Bill Haddad
Earnings Scheduled For May 12, 2022
Benzinga Insights
Tuesday, April 26, 2022
60 Biggest Movers From Yesterday
Lisa Levin
Monday, April 11, 2022
CORRECTION: ImmuCell Reported Prelim. Q1 Resu...
Bill Haddad
ImmuCell Sees Prelim. FY22 Sales $21.1M, Up 4...
Bill Haddad
Immucell 8-K Shows Co. Initiated Added Invest...
Benzinga Newsdesk
Immucell 8-K Shows Co. Q1 Sales $6M vs $4.1M ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
